Skip to main content
Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
4.500
+0.150 (3.45%)
At close: May 17, 2024, 3:59 PM
4.401
-0.099 (-2.20%)
After-hours: May 17, 2024, 7:35 PM EDT

Telesis Bio Revenue

Telesis Bio had revenue of $24.63M in the twelve months ending March 31, 2024, down -12.38% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.44M, a -45.54% decrease year-over-year. In the year 2023, Telesis Bio had annual revenue of $27.51M with 0.27% growth.

Revenue (ttm)
$24.63M
Revenue Growth
-12.38%
P/S Ratio
0.30
Revenue / Employee
$179,803
Employees
137
Market Cap
7.36M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.51M74.00K0.27%
Dec 31, 202227.44M16.39M148.44%
Dec 31, 202111.04M4.47M67.93%
Dec 31, 20206.58M1.77M36.86%
Dec 31, 20194.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TBIO News

More News